Cargando…
Chronic hepatitis B and metabolic risk factors: A call for rigorous longitudinal studies
Long-term nucleos(t)ide analogue therapy in chronic hepatitis B virus (HBV) infection is effective in suppressing viral replication and reducing liver-related complications. However, HBV-related liver events can still occur in different patient sub-groups. There is emerging evidence that, similar to...
Autor principal: | Seto, Wai-Kay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343097/ https://www.ncbi.nlm.nih.gov/pubmed/30686897 http://dx.doi.org/10.3748/wjg.v25.i3.282 |
Ejemplares similares
-
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B
por: Mao, Xianhua, et al.
Publicado: (2023) -
Editorial: Scientific Rigor or Rigor Mortis?
por: Bernard, Christophe
Publicado: (2016) -
Call for more rigorous research on savant syndrome
por: Yamaguchi, Makoto
Publicado: (2011) -
New Biomarkers of Chronic Hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2019) -
Rigor Mortis
Publicado: (1888)